Research Analysts Offer Predictions for DLB Q3 Earnings

Dolby Laboratories, Inc. (NYSE:DLB) – Stock analysts at William Blair boosted their Q3 2025 earnings per share estimates for Dolby Laboratories in a research report issued to clients and investors on Wednesday, November 20th. William Blair analyst R. Schackart now anticipates that the electronics maker will earn $0.52 per share for the quarter, up from their previous estimate of $0.43. The consensus estimate for Dolby Laboratories’ current full-year earnings is $2.67 per share.

Other research analysts also recently issued research reports about the company. Rosenblatt Securities increased their price target on Dolby Laboratories from $98.00 to $100.00 and gave the stock a “buy” rating in a research note on Wednesday, November 20th. StockNews.com lowered shares of Dolby Laboratories from a “strong-buy” rating to a “buy” rating in a research report on Tuesday. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $100.00 target price on shares of Dolby Laboratories in a research note on Wednesday, November 20th.

Dolby Laboratories Trading Up 0.0 %

Shares of Dolby Laboratories stock opened at $80.33 on Monday. The business’s fifty day simple moving average is $74.50 and its 200 day simple moving average is $75.96. The firm has a market capitalization of $7.66 billion, a P/E ratio of 29.64 and a beta of 0.98. Dolby Laboratories has a 12 month low of $66.35 and a 12 month high of $90.06.

Hedge Funds Weigh In On Dolby Laboratories

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Boston Trust Walden Corp boosted its position in shares of Dolby Laboratories by 185.3% during the third quarter. Boston Trust Walden Corp now owns 1,075,076 shares of the electronics maker’s stock valued at $82,276,000 after buying an additional 698,283 shares during the period. Clifford Capital Partners LLC lifted its stake in shares of Dolby Laboratories by 3,114.7% during the 3rd quarter. Clifford Capital Partners LLC now owns 270,579 shares of the electronics maker’s stock worth $20,707,000 after acquiring an additional 262,162 shares during the last quarter. Acadian Asset Management LLC boosted its holdings in Dolby Laboratories by 39.8% during the 2nd quarter. Acadian Asset Management LLC now owns 652,651 shares of the electronics maker’s stock valued at $51,698,000 after acquiring an additional 185,884 shares during the period. Dimensional Fund Advisors LP grew its position in Dolby Laboratories by 27.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 792,828 shares of the electronics maker’s stock valued at $62,817,000 after acquiring an additional 168,744 shares during the last quarter. Finally, AQR Capital Management LLC increased its stake in Dolby Laboratories by 16.2% in the second quarter. AQR Capital Management LLC now owns 627,160 shares of the electronics maker’s stock worth $49,690,000 after purchasing an additional 87,298 shares during the period. 58.56% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, SVP John D. Couling sold 7,000 shares of the firm’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $80.50, for a total value of $563,500.00. Following the transaction, the senior vice president now directly owns 106,806 shares in the company, valued at $8,597,883. This trade represents a 6.15 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Kevin J. Yeaman sold 28,512 shares of the stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $74.12, for a total transaction of $2,113,309.44. Following the completion of the transaction, the chief executive officer now owns 83,721 shares in the company, valued at $6,205,400.52. The trade was a 25.40 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 91,591 shares of company stock valued at $7,158,807 over the last ninety days. Company insiders own 39.54% of the company’s stock.

Dolby Laboratories announced that its Board of Directors has authorized a stock buyback program on Wednesday, August 7th that permits the company to repurchase $350.00 million in shares. This repurchase authorization permits the electronics maker to purchase up to 5% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s management believes its shares are undervalued.

Dolby Laboratories Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 10th. Shareholders of record on Tuesday, December 3rd will be given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 1.64%. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.30. The ex-dividend date is Tuesday, December 3rd. Dolby Laboratories’s payout ratio is presently 48.71%.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.